CoChat

Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study

Open access
Böhm, Michael, Borer, Jeffrey, Ford, Ian, Gonzalez-Juanatey, Jose R., Komajda, Michel, Lopez-Sendon, Jose, Reil, Jan-Christian, Swedberg, Karl, Tavazzi, Luigi · 2013 · Clinical Research in Cardiology

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Background We analysed the effect of ivabradine on outcomes in heart failure (HF) patients on recommended background therapies with heart rates ≥75 bpm and <75 bpm in the SHIFT trial. A cut-off value of ≥75 bpm was chosen by the EMEA for approval for the use of ivabradine in chronic heart failure.Methods The SHIFT population was divided by baseline heart rate ≥75 or <75 bpm. The effect of ivabradine was analysed for primary composite endpoint (cardiovascular death or HF hospitalization) and other endpoints.Results In the ≥75 bpm group, ivabradine reduced primary endpoint (HR 0.76, 95 % CI 0.68-0.85, P < 0.0001), all-cause mortality (HR 0.83, 95 % CI, 0.72-0.96, P = 0.0109), cardiovascular mortality (HR 0.83, 95 % CI, (0.71-0.97, P = 0.0166), HF death (HR 0.61, 95 % CI, 0.46-0.81, P < 0.0006), and HF hospitalization (HR 0.70, 95 % CI, 0.61-0.80, P < 0.0001). Risk reduction depended on heart rate after 28 days, with the best protection for heart rates <60 bpm or reductions >10 bpm. None of the endpoints was significantly reduced in the <75 bpm group, though there were trends for risk reductions in HF death and hospitalization for heart rate <60 bpm and reductions >10 bpm. Ivabradine was tolerated similarly in both groups.Conclusion The effect of ivabradine on outcomes is greater in patients with heart rate ≥75 bpm with heart rates achieved <60 bpm or heart rate reductions >10 bpm predicting best risk reduction. Our findings emphasize the importance of identification of high-risk HF patients by high heart rates and their treatment with heart rate-lowering drugs such as ivabradine.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00392-012-0467-8

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 18 references

Cited by

See all 250

Metadata

Authors
Böhm, M., Borer, J., Ford, I., Gonzalez-Juanatey, J. R., Komajda, M., Lopez-Sendon, J., Reil, J.-C., Swedberg, K., & Tavazzi, L.
Affiliations
  • Universitätsklinikum des Saarlandes (DE)
  • SUNY Downstate Health Sciences University (US)
  • University of Glasgow (GB)
  • Hospital Universitario La Paz (ES)
  • University of Gothenburg (SE)
  • Maria Cecilia Hospital (IT)
Corresponding author
  • Böhm, Michael
  • Reil, Jan-Christian
Venue
Clinical Research in Cardiology
Published
2012-05-11
Volume
102
Issue
1
Pages
11-22
ISSN
  • 1861-0684 (ISSN-L)
  • 1861-0692
OpenAlex
W2045247934
Cited by
248
References
18
Citations by year
2026: 4 · 2025: 7 · 2024: 15 · 2023: 15 · 2022: 13 · 2021: 16 · 2020: 19 · 2019: 19 · 2018: 18 · 2017: 16 · 2016: 34 · 2015: 15 · 2014: 19 · 2013: 27 · 2012: 10
FWCI
14.61
Type
journal article
Language
en
Open access
Licence
  • other-oa
  • www.springer.com/tdm (tdm)
Locations
  • Clinical Research in Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
  • RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
Keywords
ivabradine, chronic heart failure, baseline heart rate, SHIFT trial, cardiovascular mortality, heart failure hospitalization, heart rate reduction, all-cause mortality
MeSH terms
Ivabradine, Aged, Anti-Arrhythmia Agents, Benzazepines, Chronic Disease, Double-Blind Method, Female, Heart Failure, Heart Rate, Hospitalization, Humans, Male, Middle Aged, Risk Factors, Time Factors, Proportional Hazards Models, Treatment Outcome, Disease Progression, Risk Assessment, Patient Selection, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study. https://app.cochat.ai/papers/10.1007/s00392-012-0467-8
The paper
Böhm, M., Borer, J., Ford, I., Gonzalez-Juanatey, J. R., Komajda, M., Lopez-Sendon, J., Reil, J.-C., Swedberg, K., & Tavazzi, L. (2013). Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-012-0467-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.